L. Reaby

发表

Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS‐II DCIS)

J. Forbes, P. Butow, A. Coates, 2008, Health expectations : an international journal of public participation in health care and health policy.

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up

R. Gelber, M. Piccart, G. Viale, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

J. Cuzick, J. Forbes, V. Gebski, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast restoration decision making: enhancing the process.

L. Reaby, 1998, Cancer nursing.

Abstract GS1-04: Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in patients with operable HER2-pos

R. Gelber, M. Piccart, G. Viale, 2020 .

Body image, self-concept, and self-esteem in women who had a mastectomy and either wore an external breast prosthesis or had breast reconstruction and women who had not experienced mastectomy.

L. Reaby, J. Vandervord, L. Hort, 1994, Health care for women international.

Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options

J. Forbes, N. Zdenkowski, J. Chirgwin, 2016, Supportive Care in Cancer.

Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial

M. Procter, E. de Azambuja, N. Pondé, 2022, Ecancermedicalscience.

Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer

R. Gelber, M. Piccart, J. Baselga, 2021, British Journal of Cancer.

Postmastectomy attitudes in women who wear external breast prostheses compared to those who have undergone breast reconstructions

L. Reaby, L. Hort, 1995, Journal of Behavioral Medicine.

Breast restoration decision making.

L. Reaby, 1999, Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses.

Improving decision making about clinical trial participation – a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial

J Cuzick, J. Cuzick, J. Forbes, 2014, British Journal of Cancer.

Efficacy and safety of prone positioning for patients with acute respiratory distress syndrome.

L. Aitken, J. Pierce, R. Clancy, 2000, Journal of advanced nursing.

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem).

J. Forbes, V. Gebski, P. Francis, 2014, Breast.

The quality and coping patterns of women's decision‐making regarding breast cancer surgery

L. Reaby, 1998, Psycho-oncology.

Reasons Why Women Who Have Mastectomy Decide to Have or Not to Have Breast Reconstruction

L. Reaby, L L Reaby, 1998, Plastic and reconstructive surgery.

Students in transit: using a self-directed preceptorship package to smooth the journey.

L. Grealish, C. Trevitt, L. Reaby, 2001, Journal of Nursing Education.

Keeping faith with trial volunteers

M. Piccart, J. Baselga, A. Goldhirsch, 2007, Nature.

The effectiveness of an education program to teach Australian nurses comprehensive physical assessment skills.

L. Reaby, 1990, Nurse education today.

Teaching physical assessment skills: the state of the art.

L. Reaby, J. James, 1987, The Australian nurses' journal. Royal Australian Nursing Federation.

Physical assessment skills for RNs?

L. Reaby, J. James, 1987, The Australian nurses' journal. Royal Australian Nursing Federation.

Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC).

R. Gelber, J. Baselga, G. Viale, 2018 .

Final analysis of a randomized comparison of letrozole (Let) vs observation (Obs) as late reintroduction of adjuvant endocrine therapy (AET) for postmenopausal women with hormone receptor positive (HR+) breast cancer (BC) after completion of prior AET: ANZBCTG 0501 (LATER).

J. Forbes, V. Gebski, F. Boyle, 2015 .

Abstract PS7-21: Timelines to initiate an adjuvant phase III trial across the globe: A sub-analysis of the APHINITY trial

M. Procter, N. Pondé, E. Clark, 2021 .